Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ITSEC Asia Tbk. (CYBR) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

ITSEC Asia Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

ITSEC Asia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? ITSEC Asia Tbk. trades at Rp575 (market cap 7.75T), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 651.75B). The key difference: ITSEC Asia Tbk. is far larger — about 11.9× UBC Medical Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

CYBRLABS
Market Cap
7.75T651.75B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CYBR
View details
LABS
View details

About ITSEC Asia Tbk.

PT ITSEC Asia Tbk (the “Company”) was established based on Notarial Deed No. 7 dated April 12, 2010 of Refizal, S.H., M.Hum., notary in Jakarta. The Company started its commercial operations in 2010.

Read more on CYBR

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS